Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$458.39M
Total Bought
$90.31M
Total Sold
$0
Net Transaction
+$90.31M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
SPDR GOLD TR(GLD)555,0001,062,500+507,50098,940182,16639.74%+83,226
ALECTOR INC980,8941,307,858+326,9645,8958,4751.85%+2,580
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440105,979107,24023.39%+1,261
RAPT THERAPEUTICS INC571,233657,899+86,66610,68210,9342.39%+252
SURROZEN INC802,9631,315,463+512,5004426450.14%+203
PMV PHARMACEUTICALS INC2,545,2422,627,643+82,40115,93316,1343.52%+201
ORIC PHARMACEUTICALS INC(ORIC)747,550989,410+241,8605,8015,9861.31%+185
SURROZEN INC0170,833+170,833070.00%+7
NGM BIOPHARMACEUTICALS INC746,674992,168+245,4941,9341,0620.23%-872
TENAYA THERAPEUTICS INC915,7051,015,705+100,0005,3752,5900.57%-2,785
FOGHORN THERAPEUTICS INC1,573,7611,573,761011,0797,8691.72%-3,210
SPDR S&P 500 ETF TR(SPY)246,250246,2500109,158105,26722.96%-3,891
23ANDME HOLDING CO10,243,12210,243,122017,92510,0152.18%-7,911
Page 1 of 1